The aim of the news bulletin is to increase the awareness of adverse reactions related to health products amongst healthcare professionals, and to promote adverse reaction reporting to health products.

This issue includes topics such as reports of lymphadenitis following administration of BCG Vaccine SSI^®, voluntary worldwide recall of drotrecogin alfa (Xigris^®), birth defects in infants associated with in utero exposure to long-term, high-dose fluconazole, recent Product Safety-related articles published on HSA website, bleeding events associated with dabigatran etexilate (Pradaxa^®), updates on adulterated health products reported to HSA, suspension of the sales of Zerin^® (paracetamol) tablets, summary of safety advisories issued by HSA, pharmaceutical and medical device companies, voluntary recall of Bayer Contour^TM TS blood glucose test strips in Singapore and HSA’s advisory on the use of pioglitazone.

Download the latest bulletin here : December 2011 Volume 13 No. 3